Glass Jacobson Investment Advisors’s AbbVie ABBV Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$184K	Buy	732 +3	+0.4%	+$645	0.06%	209
2026 Q1	$159K	Buy	729 +2	+0.3%	+$444	0.05%	214
2025 Q4	$166K	Sell	727 -48	-6%	-$10.9K	0.06%	200
2025 Q3	$179K	Buy	775 +2	+0.3%	+$407	0.06%	196
2025 Q2	$143K	Sell	773 -37	-5%	-$6.88K	0.06%	200
2025 Q1	$144K	Hold	810	–	–	0.05%	259
2024 Q4	$144K	Buy	810 +44	+6%	+$8.09K	0.05%	259
2024 Q3	$151K	Buy	766 +3	+0.4%	+$560	0.05%	244
2024 Q2	$131K	Buy	763 +2	+0.3%	+$331	0.05%	246
2024 Q1	$139K	Sell	761 -5,047	-87%	-$870K	0.05%	241
2023 Q4	$900K	Sell	5,808 -347	-6%	-$50.6K	0.37%	87
2023 Q3	$917K	Buy	6,155 +3	+0%	+$440	0.42%	74
2023 Q2	$829K	Buy	+6,152	New	+$902K	0.38%	78
2022 Q4	$1.01M	Buy	+6,277	New	+$962K	0.5%	55

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Glass Jacobson Investment Advisors's ABBV Position: Q2 2026 in Review

Glass Jacobson Investment Advisors increased its AbbVie (ABBV) stake by 0.41% in Q2 2026, buying an estimated $645 and bringing the position to 732 shares worth $184K. The position accounts for 0.06% of the portfolio, ranked #209.

Glass Jacobson Investment Advisors first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.01M in Q4 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Glass Jacobson Investment Advisors held 732 shares of AbbVie worth $184K as of Q2 2026.
Glass Jacobson Investment Advisors bought 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.06% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #209 holding.
Glass Jacobson Investment Advisors first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Glass Jacobson Investment Advisors's AbbVie position peaked at $1.01M in Q4 2022.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.